Combined Use of Low-dose Sugammadex Plus Neostigmine Administered for Reversal of Rocuronium

NCT03328312 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Incidence of Postoperative Residual Curarization

Interventions

DRUG: Sugammadex
DRUG: neostigmine+atropine
DRUG: neostigmine+atropine+sugammadex

Sponsor

Iuliu Hatieganu University of Medicine and Pharmacy